Tacrolimus for induction therapy in active Crohn's disease

The primary objective is to evaluate the efficacy and safety of tacrolimus as induction therapy for active Crohn's disease.

This is a protocol.

Health topics:

Published:

3 October 2018

Authors:

Amine L, Abdelgadir IS, Neves K, Elawad M, Hassan A, Akobeng AK

Was this helpful? Donate.

If you found this evidence helpful, please consider donating to Cochrane. We are a charity that produces accessible evidence to help people make health and care decisions.
Donate
Print
PDF
Citation
Amine L, Abdelgadir IS, Neves K, Elawad M, Hassan A, Akobeng AK. Tacrolimus for induction therapy in active Crohn's disease. Cochrane Database of Systematic Reviews 2018, Issue 10. Art. No.: CD013142. DOI: 10.1002/14651858.CD013142